![]() "Cedar Clinical Research has unique expertise conducting clinical trials and research studies in neuropsychiatry for a variety of sponsors. "We're proud to partner with Merck and support its innovative neuroscience work to develop a potential new drug for treatment-resistant depression," said Dr. In mid-March, Novamind announced that it had been selected as a key research site for a clinical trial focused on treatment-resistant depression by Merck & Co., a major pharmaceutical company. Robison is one of the coordinating investigators for the Phase 3 MDMA trial for PTSD, and Janssen was a client for its Spravato study. "The clinics provide innovative modalities using psychedelic medicine," Conforti noted, "including ketamine and Spravato."įor Cedar Clinical Research, the clients are drug developers. There currently are four Cedar Psychiatry clinics, which last year saw 20,000 client visits, a 100% increase over the prior year. Reid Robison, acquiring his two businesses, the Cedar Psychiatry network of clinics and Cedar Clinical Research, a contract research organization. The company partnered with psychiatrist Dr. We set out to build a company focused on the clinic and clinical research site, the places where people were going to have these experiences," Conforti explained. ![]() "Our investment thesis was, in short, to find the people that are treating people with these innovative modalities today, in jurisdictions where it's legal, and partner with them and support them. "We saw the data coming out of Johns Hopkins and Imperial College and understood very quickly that there was a model of care there that was innovative and different from the standard of care," Conforti told Streetwise Reports. (NM:CSE) was founded in 2019 by CEO Yaron Conforti and two partners. Food and Drug Administration (FDA) approved esketamine nasal spray (Spravato) for treatment-resistant depression. Johns Hopkins University and Imperial College London have both set up psychedelic research centers, and ketamine infusions are now being used as treatments for depression, eating disorders, anxiety, PTSD and other conditions. The last few years has seen a major shift in attitudes on psychedelic drugs, as they have moved from fringe to the subject of serious study by respected medical institutions.
0 Comments
Leave a Reply. |